Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Betere overleving na stoppen met roken bij NSCLC-diagnose
mrt 2024 | Longoncologie